Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Plant Foods Hum Nutr ; 65(2): 91-8, 2010 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-20186490

RESUMO

The phenolic compounds and flavonoids were determined from the extracts of Withania somnifera root (WSREt) and leaf (WSLEt). The WSREt has 28.26 mg/g total phenolic compounds and 17.32 mg/g flavonoids, whereas WSLEt has 5.4 mg/g total phenolic compounds and 5.1 mg/g flavonoids. The WSREt, WSLEt and glibenclamide were orally administered daily to diabetic rats for 8 weeks. After the treatment, the levels of urine sugar, blood glucose, liver glycogen, and antioxidants like vitamin C and E in plasma and superoxide dismutase (SOD), catalase (CAT), thiobarbituric acid reactive substances (TBARS), glutathione peroxidase (GPx), glutathione-S-transferase (GST) and reduced glutathione (GSH) in liver, kidney and heart were determined. Diabetic rats showed a significant (p < 0.05) elevation in glucose and TBARS and a significant (p < 0.05) reduction in glycogen, vitamin C and E, SOD, CAT, GPx, GST, and GSH levels when compared to normal control rats. Administration of WSREt, WSLEt and glibenclamide to diabetic rats restored the levels to normal. In the light of aforesaid facts, it is suggested that the presence of phenolic compounds including flavonoids in W. somnifera root and leaf extracts and their antioxidant activity may play a vital role in reduction of blood glucose level in alloxan-induced diabetic rats.


Assuntos
Antioxidantes/uso terapêutico , Glicemia/metabolismo , Diabetes Mellitus Experimental/tratamento farmacológico , Suplementos Nutricionais , Hipoglicemiantes/uso terapêutico , Extratos Vegetais/uso terapêutico , Withania/química , Animais , Antioxidantes/metabolismo , Antioxidantes/farmacologia , Diabetes Mellitus Experimental/sangue , Flavonoides/farmacologia , Flavonoides/uso terapêutico , Glibureto/farmacologia , Glibureto/uso terapêutico , Glicogênio/sangue , Hipoglicemiantes/farmacologia , Masculino , Fenóis/farmacologia , Fenóis/uso terapêutico , Fitoterapia , Extratos Vegetais/farmacologia , Folhas de Planta , Raízes de Plantas , Polifenóis , Ratos , Ratos Wistar , Substâncias Reativas com Ácido Tiobarbitúrico
2.
Plant Cell Rep ; 27(11): 1731-40, 2008 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-18704429

RESUMO

Two transgenic lines, of Nicotiana benthamiana expressing Turnip crinkle virus (TCV)-coat protein (CP) gene with contrasting phenotype, the highest (#3) and the lowest (#18) CP expressers, were selected and challenged with the homologous TCV. The former, the highest expresser, showed nearly five times more CP expression than the latter. Progenies of #3 and #18 lines showed 30 and 100% infection rates, respectively. The infected progenies of #3 line showed mild and delayed symptom with TCV. This is a coat protein-mediated resistance (CP-MR), and its resistance level is directly proportional to CP transgene expression. However, CP-MR of the transgenic plants was specific only for TCV but not for heterologous viruses. Newly growing leaves of those infected progenies of #3 line did not show any visible symptoms at 4-week post-inoculation (wpi) with TCV, suggesting a reversal from infection. This was confirmed by RT-PCR analysis with the disappearance of the target at 4 wpi. This is a case of RNA-mediated resistance, and a threshold level of transgene expression may be needed to achieve the silent state. To confirm the RNA silencing, we infiltrated Agrobacterium carrying TCV-CP into leaves of progenies of #3 and performed RT-PCR analysis. The results indicate that TCV-CP's suppressor activity against RNA silencing itself can be silenced by the homologous expression of TCV-CP in the transgenic plants. The transgenic plants containing TCV-CP seem to be a model system to study viral protection mediated by a combination of protein and RNA silencing.


Assuntos
Proteínas do Capsídeo/genética , Carmovirus/genética , Nicotiana/genética , Plantas Geneticamente Modificadas/genética , Sequência de Bases , Western Blotting , Primers do DNA , Ensaio de Imunoadsorção Enzimática , Plantas Geneticamente Modificadas/virologia , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Nicotiana/virologia , Transcrição Gênica
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...